• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Savara, Inc. - Common Stock (NQ:SVRA)

    2.475 +0.065 (+2.70%)
    Streaming Delayed Price Updated: 2:53 PM EDT, Jul 23, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 306,937
    Open 2.420
    Bid (Size) 2.470 (29)
    Ask (Size) 2.480 (11)
    Prev. Close 2.410
    Today's Range 2.380 - 2.480
    52wk Range 1.890 - 4.740
    Shares Outstanding 114,066,080
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Savara Announces New Employment Inducement Grant
    From Savara Inc.
    Via Business Wire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc. - SVRA
    From Pomerantz LLP
    Via GlobeNewswire

    Performance

    YTD
    -19.4%
    -19.4%
    1 Month
    +14.6%
    +14.6%
    3 Month
    -23.1%
    -23.1%
    6 Month
    -11.6%
    -11.6%
    1 Year
    -46.4%
    -46.4%

    More News

    Read More
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc. - SVRA
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc. - SVRA
    Via ACCESS Newswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc. - SVRA
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc. - SVRA
    Via ACCESS Newswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc. - SVRA
    Via ACCESS Newswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc. - SVRA
    Via ACCESS Newswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. – SVRA
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc. - SVRA
    Via ACCESS Newswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc. - SVRA
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc. - SVRA
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc. - SVRA
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. - SVRA
    From Pomerantz LLP
    Via GlobeNewswire
    This Starbucks Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
    Via Benzinga
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc. - SVRA
    From Pomerantz LLP
    Via GlobeNewswire
    Why Is Rare Lung Disease-Focused Savara Stock Trading Lower On Tuesday?
    Via Benzinga
    Here are the top movers in Tuesday's session.
    Via Chartmill
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Let's have a look at the top gainers and losers in the middle of the day of today's session.
    Via Chartmill
    Dow Surges Over 600 Points; US Durable Goods Orders Fall in April
    Via Benzinga
    Topics Stocks
    There are notable gap-ups and gap-downs in today's session.
    Via Chartmill
    Nasdaq Jumps Over 300 Points On EU Tariff Delay; AutoZone Posts Downbeat Earnings
    Via Benzinga
    Stay updated with the stocks that are on the move in today's pre-market session.
    Via Chartmill
    Savara Receives Refusal to File (RTF) Letter From the U.S. Food and Drug Administration (FDA) for the Biologics License Application (BLA) for MOLBREEVI* to Treat Patients With Autoimmune Pulmonary Alveolar Proteinosis (autoimmune PAP)
    From Savara Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Savara, Inc. - Common Stock publicly traded?
    Yes, Savara, Inc. - Common Stock is publicly traded.
    What exchange does Savara, Inc. - Common Stock trade on?
    Savara, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Savara, Inc. - Common Stock?
    The ticker symbol for Savara, Inc. - Common Stock is SVRA on the Nasdaq Stock Market
    What is the current price of Savara, Inc. - Common Stock?
    The current price of Savara, Inc. - Common Stock is 2.475
    When was Savara, Inc. - Common Stock last traded?
    The last trade of Savara, Inc. - Common Stock was at 07/23/25 02:53 PM ET
    What is the market capitalization of Savara, Inc. - Common Stock?
    The market capitalization of Savara, Inc. - Common Stock is 282.31M
    How many shares of Savara, Inc. - Common Stock are outstanding?
    Savara, Inc. - Common Stock has 282M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.